Sales of syringes and needles in GCC are set to rise at a 5.40% CAGR through 2034. Demand outlook for syringes and needles in GCC indicates crossing USD 688.5 million in 2024. By 2034, sales projections for syringes and needles in GCC signify attaining a valuation of USD 1,164.90 million.
| Attributes | Details |
|---|---|
| Industry Size of GCC in 2024 | USD 688.5 million |
| Expected Industry Size of GCC in 2034 | USD 1,164.90 million |
| Forecasted CAGR between 2024 to 2034 | 5.40% |
Explore FMI!
Book a free demo
Proliferating Telemedicine Platforms and Remote Healthcare Delivery Models to Boost Demand
The GCC region's telemedicine and remote healthcare delivery trends are propelling demand for syringes and needles. Patients must either self-administer injections or receive injections from visiting healthcare experts as video consultations and home-based healthcare grow common. Manufacturing home-use syringes and needles with user-friendly designs and packaging intended for remote distribution can be opportunistic.
Several businesses are hopping on this trend, largely by alliances. For instance, in January 2024, e& business and Burjeel Holdings, one of the top healthcare service providers in the MENA region, made two historic collaborations aimed at changing healthcare in the UAE and beyond.
These include the introduction of a groundbreaking telemedicine services initiative and a strategic memorandum of understanding (MoU), both of which will change the landscape of healthcare delivery.
Government Initiatives and Regulations to Foster Innovation and Growth
Syringe and needle supply and demand in the GCC region are rising due to government-led initiatives to elevate healthcare standards and regulatory compliance. Regulations emphasizing safety-engineered equipment and conformity to quality standards foster an atmosphere favorable for innovation and revenue growth.
Manufacturers can gain a competitive edge in the heavily regulated GCC healthcare industry by showcasing compliance with regulatory standards, investing in quality management systems, and encouraging transparency and integrity in their operations.
By 2030, the Kingdom of Saudi Arabia's Council of Cooperative Health Insurance (CCHI) hopes to insure around half of the population and play a significant role in shaping the future of the healthcare industry. In 2022, Qatar enacted new legislation requiring insurance, while Oman and Bahrain likewise pursued universal health coverage.
Expanding Healthcare Infrastructure in the GCC Region Leads to a Surge in Demand
The GCC region's healthcare infrastructure expansion offers a favorable environment for growth. Demand for medical supplies is rising with governments prioritizing a robust healthcare infrastructure to meet the needs of urban and expanding populations. Syringe and needle manufacturers can benefit by forming strategic connections with regional distributors and having flexible production capabilities to gain a firm footing in the GCC region.
In March 2024, the Ministry of Health and Prevention (MoHAP) launched the Patient Safety Friendly Hospitals program. This initiative is a key step toward ensuring the provision of high-quality healthcare services in accordance with global best practices.
The program, launched in partnership with the World Health Organization (WHO), seeks to promote patient safety by developing recognized standards that improve hospital performance. Providing syringe and needle supplies in such initiatives can benefit businesses in this industry.
| Leading Product for Syringes and Needles in GCC | Hypodermic |
|---|---|
| Total Value Share (2024) | 85.40% |
Chronic conditions, including diabetes, heart disease, and respiratory issues, are becoming more common in GCC countries. According to the International Diabetes Federation (IDF), most of the Gulf Cooperation Council (GCC) countries have high prevalence rates of prediabetes (above 15%) and diabetes (above 20%).
These rates rank among the top in the world. Hypodermic syringes and needles are in high demand as the principal drug delivery tool since managing these disorders requires numerous injections of insulin and other therapeutic agents.
Hypodermic syringes and needles are favored in healthcare settings because of their safety features, precision, and convenience. In order to reduce the risk of contamination, prescription mistakes, and needlestick injuries, healthcare practitioners in the GCC region are using these in response to an increasing focus on patient safety and infection control.
| Leading Usability for Syringes and Needles in GCC | Disposable |
|---|---|
| Total Value Share (2024) | 80.30% |
GCC countries invest in health promotion initiatives, screening programs, and immunization campaigns as preventative healthcare measures. Disposable syringes and needles are in high demand in this region because they make it easier to administer drugs, immunizations, and diagnostic tests safely and effectively, which is essential in supporting these programs.
Healthcare practitioners emphasize using disposable syringes and needles to reduce the risk of healthcare-associated infections (HAIs) and provide a sterile environment for patient care as infection control and patient safety become increasingly pertinent in the GCC region.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Kingdom of Saudi Arabia | 5.60% |
| United Arab Emirates | 5.70% |
| Qatar | 5.50% |
| Bahrain | 4.60% |
| Oman | 5.30% |
Demand for syringes and needles in the Kingdom of Saudi Arabia (KSA) to amplify at a 5.60% CAGR through 2034. The Vision 2030 plan of the KSA government encompasses a range of ambitious healthcare programs designed to improve healthcare accessibility, foster innovation, and enhance infrastructure. Manufacturers can participate in hospital development projects, medical equipment procurement, and improving healthcare service delivery.
The Saudi Arabian government's decision to privatize healthcare services is creating opportunities for the private sector to engage and invest in the healthcare sector. Modernizing medical facilities, adopting advanced equipment and upgrading medical equipment are all priorities for private healthcare providers.
Sales of syringes and needles in the United Arab Emirates (UAE) to surge at a 5.70% CAGR through 2034. The free zones in the UAE provide a business-friendly atmosphere with tax breaks, streamlined regulations, and access to top-notch infrastructure.
Free zones like Dubai Healthcare City (DHCC) and the Khalifa Industrial Zone (KIZAD) in Abu Dhabi provide expedited procedures for producing, distributing, and exporting medical products, including needles and syringes. Manufacturers can boost competitiveness in the UAE and abroad, maximize supply chain efficiency, and save operating costs by taking advantage of free zone benefits.
The syringe and needle industry expansion in Qatar is estimated at a 5.50% CAGR through 2034. Manufacturers of syringes and needles have an opportunity to produce specialized medical equipment for sports injury management, rehabilitation, and wellness therapies, given Qatar's expanding focus on sports medicine and wellness tourism.
There is a need for top-notch medical supplies to assist athletes' healthcare demands because Qatar organizes important sports events like the World Cup and the Qatar National Sports Day. Manufacturers can tweak their offerings to fit the needs of wellness centers and sports medicine professionals, taking advantage of an exclusive niche and enhancing Qatar's stature as a sports and wellness destination.
Demand for syringes and needles in Bahrain to rise at a 4.60% CAGR through 2034. Internationally recognized health and safety standards for syringes and needles are in high demand due to Bahrain's emphasis on regulatory compliance and healthcare quality accreditation.
In order to prove their dedication to quality and patient safety, Bahraini healthcare institutions apply for certification from groups like the Health Authority Bahrain (NQVHA) and the Joint Commission International (JCI).
Manufacturers can set themselves apart from the competition by securing the necessary endorsements and certifications, which will help them establish credibility as reliable medical device providers in Bahrain.
Sales of syringes and needles in Oman to increase at a 5.30% CAGR through 2034. The prevalence of chronic diseases, including cardiovascular disease, diabetes, and respiratory disorders, is rising in Oman. In Oman, 40.3% of people have hypertension, 24.1% have a BMI of obesity, 33.6% have total cholesterol, and anemia affects 32.2% of non-pregnant women and 20% of men.
The management of several chronic health conditions necessitates routine injections, which increases its demand in medical institutions and home care environments. It is an opportunity for manufacturers to fulfill the unique needs of Oman's healthcare system and populace by providing a selection of specialty syringes and needles that are made for accurate dose administration and patient comfort.
The syringe and needle industry in the GCC region is extremely competitive, with numerous established global businesses competing alongside regional players. Becton, Dickinson, and Company (BD) is an industry leader, relying on its large product range, robust distribution network, and sterling reputation to stay ahead.
Terumo Corporation, Smiths Medical, and Nipro Corporation constitute the top rivals contending for industry share, with each offering a varied selection of syringes and needles tailored to different medical specializations and uses.
Recent Developments
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2024 | USD 688.5 million |
| Projected Industry Size by 2034 | USD 1,164.90 million |
| Anticipated CAGR between 2024 to 2034 | 5.40% CAGR |
| Historical Analysis of Demand for Syringes and Needles in GCC | 2019 to 2023 |
| Demand Forecast for Syringes and Needles in GCC | 2024 to 2034 |
| Report Coverage | Industry Size, Industry Trends, Analysis of Key Factors Influencing Syringes and Needles in GCC, Insights on Global Players and their Industry Strategy in GCC, Ecosystem Analysis of Local and Regional GCC Manufacturers |
| Key Countries Analyzed while Studying Opportunities in Syringes and Needles in GCC | Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), Qatar, Bahrain, Oman, Kuwait |
| Key Companies Profiled | Becton, Dickinson and Company (BD); Terumo Corporation; Smiths Medical; Nipro Corporation; B. Braun Melsungen AG; Cardinal Health, Inc.; Gerresheimer AG; Hindustan Syringes & Medical Devices Ltd. (HMD); Medtronic plc; Fresenius SE & Co. KGaA |
The expected CAGR until 2034 stands at 5.40%.
Demand in GCC is projected to reach USD 1,164.90 million by 2034.
Rise of telemedicine influences the demand in GCC.
Manufacturers in GCC are emphasizing expansion through partnership strategies.
Hypodermic products are highly popular in the industry.
Anti-hyperglycemic Agents Market: Growth, Trends, and Assessment for 2025 to 2035
At Home Heart Health Testing Market Analysis - Size & Industry Trends 2025 to 2035
Protein Diagnostics Market Share, Size and Forecast 2025 to 2035
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Industry Analysis of Syringe and Needle in GCC
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
